Cargando…
Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
PURPOSE: Xeroderma pigmentosum group D (XPD) codes for a DNA helicase involved in nucleotide excision repair that removes platinum-induced DNA damage. Genetic polymorphisms of XPD may affect DNA repair capacity and lead to individual differences in the outcome of patients after chemotherapy. This st...
Autores principales: | Wu, Wenting, Li, Huan, Wang, Huibo, Zhao, Xueying, Gao, Zhiqiang, Qiao, Rong, Zhang, Wei, Qian, Ji, Wang, Jiucun, Chen, Hongyan, Wei, Qingyi, Han, Baohui, Lu, Daru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315552/ https://www.ncbi.nlm.nih.gov/pubmed/22479369 http://dx.doi.org/10.1371/journal.pone.0033200 |
Ejemplares similares
-
Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer
por: Song, Xiao, et al.
Publicado: (2017) -
Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation
por: Sun, Chang, et al.
Publicado: (2018) -
A pharmacogenetics study of platinum-based chemotherapy in lung cancer: ABCG2 polymorphism and its genetic interaction with SLC31A1 are associated with response and survival
por: Wang, Liyan, et al.
Publicado: (2021) -
Predictive Value of XPD Polymorphisms on Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Qiu, Mantang, et al.
Publicado: (2013) -
Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients
por: Nairuz, Tahsin, et al.
Publicado: (2021)